There are many potential options for treating left ventricular dysfunction, from medical to device therapies. Dr. Howard Eisen, Thomas J. Vischer Professor of Medicine and chief of the division of cardiology at Drexel University College of Medicine and Hahnemann University Hospital, in Philadelphia, Pennsylvania, outlines the roles of bypass surgery, percutaneous coronary intervention, cardiac resynchronization, surgical ventricular reconstruction and pharmacologic therapies for treating this condition. Specifically, he describes results of the recent Surgical Treatment for Ischemic Heart Failure, or STITCH, trial, and also tells us about the various ventricular-assist device options currently available. Dr. Alfred Bove hosts.
The Spectrum of Treatment for Left Ventricular Dysfunction
Restart
Resume
Share this program on:
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Details
Presenters
Recommended
Details
Presenters
Overview
There are many potential options for treating left ventricular dysfunction, from medical to device therapies. Dr. Howard Eisen, Thomas J. Vischer Professor of Medicine and chief of the division of cardiology at Drexel University College of Medicine and Hahnemann University Hospital, in Philadelphia, Pennsylvania, outlines the roles of bypass surgery, percutaneous coronary intervention, cardiac resynchronization, surgical ventricular reconstruction and pharmacologic therapies for treating this condition. Specifically, he describes results of the recent Surgical Treatment for Ischemic Heart Failure, or STITCH, trial, and also tells us about the various ventricular-assist device options currently available. Dr. Alfred Bove hosts.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
CME/CE
Implementing a Multidisciplinary Approach to Heart Failure: Patient Identification and Treatment Using Novel Device Therapy
0.25 credits
<p>Implementing a Multidisciplinary Approach to Heart Failure: Patient Identification and Treatment Using Novel Device Therapy</p>
CME/CE
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
0.25 credits
<p>Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective</p>
CME/CE
IgG4-RD Case Conversations: Systemic Disease Infiltrating the Skull Base
0.50 credits
<p>IgG4-RD Case Conversations: Systemic Disease Infiltrating the Skull Base</p>
CME/CE
IgG4-RD Case Conversations: Retroperitoneal Fibrosis with Refractory Ureteral Involvement
0.50 credits
<p>IgG4-RD Case Conversations: Retroperitoneal Fibrosis with Refractory Ureteral Involvement</p>
CME/CE
IgG4-RD Case Conversations: IgG4-related Autoimmune Pancreatitis and Cholangitis
0.25 credits
<p>IgG4-RD Case Conversations: IgG4-related Autoimmune Pancreatitis and Cholangitis</p>
CME/CE
Establishing Best Practices for Collaborative Care for Patients with ASCVD Between Academic and Rural Providers
1.00 credits
<p>Establishing Best Practices for Collaborative Care for Patients with ASCVD Between Academic and Rural Providers</p>
CME/CE
FAIR-HF2 Trial: Ferric Carboxymaltose Assessment of Morbidity and Mortality in Patients with Iron Deficiency and Chronic Heart Failure
<p>FAIR-HF2 Trial: Ferric Carboxymaltose Assessment of Morbidity and Mortality in Patients with Iron Deficiency and Chronic Heart Failure</p>
MinuteCE®
Second-line Chemotherapy Options in Metastatic PDAC
0.25 credits
<p>Second-line Chemotherapy Options in Metastatic PDAC</p>
Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?